The CoBrCa meeting - discussing difficult issues and controversies in breast cancer

The CoBrCa meeting - discussing difficult issues and controversies in breast cancer

VJOncology

3 years
735 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Bruce Mann, MBBS, PhD, FRACS, of the Peter MacCallum Cancer Centre, Victoria, Australia, talks about the World Congress on Controversies in Breast Cancer (CoBrCa) 2016 meeting. He starts by explaining that CoBrCa 2016 is the second conference on breast cancer with the first in 2015 being highly successful. He explains that the concept of CoBrCa is to cover clinical controversies and issues that doctors looking after patients with breast cancer come across each week in their clinical practice where the answers are not clear cut and where there are differences of opinion amongst doctors. CoBrCa aims to solve these conflicting views and help doctors understand which options are best. The meeting includes experts from around the world who present either one or other side of various debates. After both sides are heard there is a discussion where the topic of debate is discussed further. He explains that he believes it is very interesting for all doctors to hear an expert from a different country debate one or other side of a controversial area.
Filmed at the 2016 World Congress on Controversies in Breast Cancer, in Barcelona, Spain.
Up Next Autoplay
JAVELIN Study: How Does This Affect Clinicians?
JAVELIN Study: How Does This Affect Clinicians?
Category: Urology
1 Views
Cancer-News 4 hours
What happened to patients with progression of disease?
What happened to patients with progression of disease?
Category: Urology
3 Views
Cancer-News 4 hours
Phase III JAVELIN Study in Urothelial Cancer @tompowles1
Phase III JAVELIN Study in Urothelial Cancer @tompowles1
Category: Urology
1 Views
Cancer-News 4 hours
Radiotherapy in Localized Prostate Cancer: What is next for treatment?
Radiotherapy in Localized Prostate Cancer: What is next for treatment?
Category: Prostate Cancer
1 Views
Cancer-News 3 days
The Impact of Therapy with External-Beam Radiotherapy
The Impact of Therapy with External-Beam Radiotherapy
Category: Prostate Cancer
1 Views
Cancer-News 3 days
Is there a correlation between the target volume of radiation?
Is there a correlation between the target volume of radiation?
Category: Prostate Cancer
0 Views
Cancer-News 3 days
NantKwest and ImmunityBio Announce Complete Response in Metastatic Pancreatic Cancer in the First Patient to Receive PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) Combined with...
NantKwest and ImmunityBio Announce Complete Response in Metastatic Pancreatic Cancer in the First Patient to Receive PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) Combined with...
Category: Pancreatic Cancer
0 Views
Cancer-News 3 days
Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial
Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial
Category: Prostate Cancer
2 Views
Cancer-News 3 days
Servier's R&D Efforts in Oncology #ASH #ASH19
Servier's R&D Efforts in Oncology #ASH #ASH19
Category: News
1 Views
ash 3 days
ArcherDX Personalized Cancer Monitoring (PCM) Technology Designated by FDA as Breakthrough Device
ArcherDX Personalized Cancer Monitoring (PCM) Technology Designated by FDA as Breakthrough Device
Category: News
0 Views
Cancer-News 5 days